These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18370219

  • 1. Gene delivery to dystrophic muscle.
    Wells KE, McMahon J, Foster H, Ferrer A, Wells DJ.
    Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
    [Abstract] [Full Text] [Related]

  • 2. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
    Kapsa RM, Wong SH, Quigley AF.
    Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
    [Abstract] [Full Text] [Related]

  • 3. High-efficiency plasmid gene transfer into dystrophic muscle.
    Gollins H, McMahon J, Wells KE, Wells DJ.
    Gene Ther; 2003 Mar; 10(6):504-12. PubMed ID: 12621454
    [Abstract] [Full Text] [Related]

  • 4. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation.
    Murakami T, Nishi T, Kimura E, Goto T, Maeda Y, Ushio Y, Uchino M, Sunada Y.
    Muscle Nerve; 2003 Feb; 27(2):237-41. PubMed ID: 12548532
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS, Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, Balkir L, Morgan J, Moreland MS, Feero GW, Epperly M, Huard J.
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [Abstract] [Full Text] [Related]

  • 6. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH, Sirsi SR, Latta DR, Lutz GJ.
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [Abstract] [Full Text] [Related]

  • 7. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J, Lou F, Rabinowitz A, Yin H, Rosenfeld J, Wilton SD, Partridge TA, Lu QL.
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [Abstract] [Full Text] [Related]

  • 8. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP, Bilbao R, Koppanati BM, Cai L, O'Day TL, Jiang Z, Zheng H, Watchko JF, Clemens PR.
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [Abstract] [Full Text] [Related]

  • 9. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
    Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, Partridge TA, Wilton SD.
    Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521
    [Abstract] [Full Text] [Related]

  • 10. Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy.
    Ferrer A, Wells KE, Wells DJ.
    Gene Ther; 2000 Sep; 7(17):1439-46. PubMed ID: 11001363
    [Abstract] [Full Text] [Related]

  • 11. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
    Liu F, Nishikawa M, Clemens PR, Huang L.
    Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
    [Abstract] [Full Text] [Related]

  • 12. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
    Vilquin JT, Kennel PF, Paturneau-Jouas M, Chapdelaine P, Boissel N, Delaère P, Tremblay JP, Scherman D, Fiszman MY, Schwartz K.
    Gene Ther; 2001 Jul; 8(14):1097-107. PubMed ID: 11526457
    [Abstract] [Full Text] [Related]

  • 13. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.
    Liang KW, Nishikawa M, Liu F, Sun B, Ye Q, Huang L.
    Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786
    [Abstract] [Full Text] [Related]

  • 14. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, Tanouchi A, Yamamoto H, Li J, Chamberlain JS, Xiao X, Takeda S.
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [Abstract] [Full Text] [Related]

  • 15. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B, Li J, Qiao C, Chen C, Hu P, Zhu X, Zhou L, Bogan J, Kornegay J, Xiao X.
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [Abstract] [Full Text] [Related]

  • 16. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O.
    Science; 2004 Dec 03; 306(5702):1796-9. PubMed ID: 15528407
    [Abstract] [Full Text] [Related]

  • 17. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A, Hijikata T, Miyagoe-Suzuki Y, Takeda S.
    Gene Ther; 2007 Sep 03; 14(17):1249-60. PubMed ID: 17581597
    [Abstract] [Full Text] [Related]

  • 18. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, Cornelio F, Pozza O, Karpati G, Gilbert R, Mora M.
    Gene Ther; 2003 May 03; 10(9):750-7. PubMed ID: 12704413
    [Abstract] [Full Text] [Related]

  • 19. Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.
    Ferrer A, Foster H, Wells KE, Dickson G, Wells DJ.
    Gene Ther; 2004 Jun 03; 11(11):884-93. PubMed ID: 14985788
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
    Bartoli M, Poupiot J, Goyenvalle A, Perez N, Garcia L, Danos O, Richard I.
    Gene Ther; 2006 Jan 03; 13(1):20-8. PubMed ID: 16107863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.